Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Bhanushali, Minal J
and
Tuite, Paul J
2004.
The evaluation and management of patients with neuroleptic malignant syndrome.
Neurologic Clinics,
Vol. 22,
Issue. 2,
p.
389.
Lambreva, E.
Vecellio, M.
Wieser, H.G.
and
Buddeberg, C.
2005.
Neurotoxische Enzephalopathie unter Neuroleptika und Lithium.
Der Nervenarzt,
Vol. 76,
Issue. 6,
p.
756.
Benjelloun, G.
Jehel, L.
Abgrall, G.
Pelissolo, A.
and
Allilaire, JF.
2005.
Syndrome catatonique et syndrome malin des neuroleptiques (à propos d’un cas).
L'Encéphale,
Vol. 31,
Issue. 6,
p.
705.
Tutuncu, Recep
Gunay, Huseyin
and
Balibey, Hakan
2012.
Olanzapine-Induced Neuroleptic Malignant Syndrome with Hypernatremia.
Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology,
Vol. 22,
Issue. 2,
p.
184.
Yıldırım, Veli
Direk, Meltem Çobanogulları
Güneş, Serkan
Okuyaz, Çetin
and
Toros, Fevziye
2017.
Neuroleptic Malignant Syndrome Associated with Valproate in an Adolescent.
Clinical Psychopharmacology and Neuroscience,
Vol. 15,
Issue. 1,
p.
76.
Rosenblatt, Kathryn
2017.
Evidence-Based Critical Care.
p.
343.
Rosenblatt, Kathryn
2020.
Evidence-Based Critical Care.
p.
323.
Sweileh, Waleed M.
2024.
Neuroleptic malignant syndrome and serotonin syndrome: a comparative bibliometric analysis.
Orphanet Journal of Rare Diseases,
Vol. 19,
Issue. 1,
Comments
No Comments have been published for this article.